In clinical trials, brain monitoring EEG is facilitating the measurement of complex clinical endpoints. EEG as a biomarker provides safe, objective and repeatable data enabling a deeper understanding of the pharmacological effects of the drug early in its development.
The benefits of collecting EEG neuroimaging insights in clinical trials.
The capacity of neurotechnologies to probe and interfere with brain activity challenges notions of identity, integrity and autonomy of human being. Recent initiatives aim to help actors in the field anticipate and address ethical, legal and social challenges, while promoting innovation in this area.
A cockpit is a highly sensitive area, where attention and mental workload have to be optimized. Latest neurotechnologies, including EEG, can track brain activity and offer neuroadaptive solutions to limit cognitive interference for safer and better operational performance.
One of the key aspects of product strategy is to generate, identify and leverage insights that will provide the foundation to reach business objectives. Today, data generated through real time brain monitoring can accompany teams throughout the design process.
Cutting edge “neuro-IA” technologies can detect the physiological impact of a cosmetic product using real-time consumers’ emotional data collected from the brain, in order to deploy a plethora of quantitative information to be used at both the conception and application stage of one product journey.
Neuroergonomics provides a multidisciplinary approach that merges elements of neuroscience, human factors, and ergonomics to study brain response to stimuli. The main goal is to utilise new types of neurotechnologies in order to create better symbiosis between a product itself, the human experience, and its environment.
Neuroscience and artificial intelligence are about to revolutionize medicine, especially psychiatry. Neurotechnologies offer a range of new tools based on objective and empirical data which will revolutionize the diagnosis and prevention of psychiatric pathologies.
Implementing a quality approach within a start-up poses particular difficulties linked to the context of innovation, agility and rapid growth. However, such an approach is essential to guarantee the sustainability of its activities and to enable it to become a leader in its market.